Adaptive Biotechnologies revenue rises 57% in 2021 to $154.3M
GeekWire
FEBRUARY 15, 2022
million in 2021, a 45% increase from 2020. Net loss for 2021 came in at $207.3 million in the fourth quarter, up 26%, with a net loss of $61.4 In a call with analysts Tuesday, CEO Chad Robins highlighted several milestones from 2021. million in 2021. million, up from $146.2 million in 2020.
Let's personalize your content